CA
XERS icon

Cliff Asness’s Xeris Biopharma Holdings XERS Stock Holding History

Cliff Asness’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
1,540,985
+146,609
+11% +$936K ﹤0.01% 1446
2026
Q1 		$8.09M Buy
1,394,376
+436,797
+46% +$2.9M ﹤0.01% 1449
2025
Q4 		$7.52M Sell
957,579
-26,021
-3% -$205K ﹤0.01% 1346
2025
Q3 		$8.01M Sell
983,600
-65,393
-6% -$434K 0.01% 1196
2025
Q2 		$4.9M Buy
1,048,993
+102,227
+11% +$468K ﹤0.01% 1298
2025
Q1 		$5.2M Buy
946,766
+111,826
+13% +$451K 0.01% 1114
2024
Q4 		$2.83M Sell
834,940
-233,176
-22% -$750K ﹤0.01% 1341
2024
Q3 		$3.04M Sell
1,068,116
-124,964
-10% -$321K ﹤0.01% 1289
2024
Q2 		$2.68M Buy
1,193,080
+52,074
+5% +$105K ﹤0.01% 1327
2024
Q1 		$2.52M Buy
1,141,006
+867,784
+318% +$2.25M ﹤0.01% 1303
2023
Q4 		$642K Buy
273,222
+230,942
+546% +$426K ﹤0.01% 1778
2023
Q3 		$78.6K Buy
42,280
+28,612
+209% +$65.5K ﹤0.01% 2254
2023
Q2 		$35.8K Sell
13,668
-17,898
-57% -$45.6K ﹤0.01% 2169
2023
Q1 		$51.5K Sell
31,566
-18,688
-37% -$23.4K ﹤0.01% 2142
2022
Q4 		$66.8K Buy
50,254
+29,712
+145% +$41.9K ﹤0.01% 2162
2022
Q3 		$32K Buy
+20,542
New +$34K ﹤0.01% 2159

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cliff Asness's XERS Position: Q2 2026 in Review

Cliff Asness increased its Xeris Biopharma Holdings (XERS) stake by 11% in Q2 2026, buying an estimated $936K and bringing the position to 1,540,985 shares worth $12.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

Cliff Asness first reported a position in XERS in Q3 2022 and has held it in 16 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Cliff Asness held 1,540,985 shares of Xeris Biopharma Holdings worth $12.2M as of Q2 2026.
  • Cliff Asness bought 146,609 Xeris Biopharma Holdings shares in Q2 2026, an estimated $936K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1446 holding.
  • Cliff Asness first reported a position in Xeris Biopharma Holdings in Q3 2022 and has held it in 16 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.